Stryker re-aligns commercial leadership
Stryker is making some executive-level changes.
The Kalamazoo-based maker of medical equipment and devices is adjusting its "commercial organizational structure," following the departure of Stuart Simpson, president of joint replacement, who left the company to pursue other career interests, according to Stryker yesterday.
The move involves the company expanding roles for a pair of its leaders.
“This change will further accelerate the globalization and collaboration opportunities being unlocked in this structure and leverage the diverse experience of these leaders,” Stryker said.
Spencer Stiles will serve as group president of orthopedics and spine and oversee Stryker’s joint replacement, spine and trauma and extremities divisions.
J. Andrew Pierce, group president of medsurg and neurotechnology, will oversee Stryker’s instruments, medical, endoscopy, sustainability and neurotechnology businesses.
Stiles and Pierce have served at Stryker for over 20 years and will continue to report to Timothy Scannell, president and COO.
Since August 2018, Scannell has been responsible for all of the company’s commercial businesses and regions.
Stryker (NYSE: SYK) offers a diverse array of medical products and services in the orthopedics, surgical, neurotechnology and spinal markets that “help improve patient and hospital outcomes.”
Its products are used in more than 100 countries around the world.
The company reported 2018 revenue of about $13.6 billion.